The Food and Drug Administration has approved another new treatment for the chronic liver disorder known as Hepatitis C.
Kalamazoo-based NephRx Corp. has been issued of a United States patent for use of its novel growth factor peptide NX002 as a potential treatment for inflammatory bowel disease.
The Detroit Medical Center Cardiovascular Institute has implemented a ground-breaking new medical technology designed to protect patients with diabetes-related arterial disease from the risk of foot or leg amputation.
The DMC Cardiovascular Institute is the first in Michigan to offer a new breakthrough technology to correct atrial fibrillation.
A new three-drug combination used to treat the blood cancer multiple myeloma may be effective as a front-line therapy for newly diagnosed patients, according to a study led by the University of Michigan Comprehensive Cancer […]